Abstract
Abstract The increasing incidence of cancer highlights the urgency for a deeper understanding of its complex pathogenesis. Recent research has identified novel post-translational modifications (PTMs) as key contributors to cancer. This review examines the role of emerging PTMs, including lactylation, crotonylation, methacrylation, succinylation, sulfhydration, β-hydroxybutyrylation, and 2-hydroxyisobutyrylation, in cancer development. We provide a comprehensive review of these novel PTMs, and their impact on proteins involved in tumor progression. Additionally, we summarize the associated enzymes, proteins, and signaling pathways, showcase the latest preclinical studies on PTMs in cancer, and offer insights into future research directions. Investigating these modifications is expected to facilitate the development of innovative and patient-centric therapies, marking a significant advancement in cancer research.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callSimilar Papers
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
